#AHA26: Lilly gets another sleep apnea win, this time with obesity pill

Eli Lilly plans to seek approval of its obesity med in obstructive sleep apnea after a positive Phase 3 trial, potentially giving it a new way to compete with Novo's far-better-selling Wegovy ...